Clinical Trial

PIC1 Injection Therapy for Relapsed/Refractory B-NHL

Name: PIC1 Injection Therapy for Relapsed/Refractory B-NHL — clinical trial record (NCT07456371)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated trial aimed at assessing the safety and efficacy of PIC1 injection in the treatment of relapsed/refractory B-cell Non-Hodgkin Lymphoma.

Trial Details

NCT Number	NCT07456371
Lead Sponsor	Chongqing Precision Biotech Co., Ltd
Conditions	Non-Hodgkin Lymphoma
Enrollment	18 participants
Start Date	2026-03
Primary Completion	2026-12 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-06